Tudor Investment Corp’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-32,162
| Closed | -$1.52M | – | 1859 |
|
|
2024
Q3 | $1.52M | Buy |
+32,162
| New | +$1.52M | 0.01% | 869 |
|
|
2024
Q2 | – | Sell |
-46,373
| Closed | -$1.86M | – | 1745 |
|
|
2024
Q1 | $1.86M | Buy |
+46,373
| New | +$1.86M | 0.01% | 695 |
|
|
2023
Q4 | – | Sell |
-27,296
| Closed | -$379K | – | 1724 |
|
|
2023
Q3 | $379K | Sell |
27,296
-24,926
| -48% | -$346K | ﹤0.01% | 1193 |
|
|
2023
Q2 | $1.2M | Buy |
52,222
+22,800
| +77% | +$524K | 0.01% | 835 |
|
|
2023
Q1 | $872K | Buy |
29,422
+1,368
| +5% | +$40.5K | 0.01% | 957 |
|
|
2022
Q4 | $700K | Buy |
28,054
+5,191
| +23% | +$130K | 0.01% | 995 |
|
|
2022
Q3 | $498K | Sell |
22,863
-18,449
| -45% | -$402K | 0.01% | 1104 |
|
|
2022
Q2 | $813K | Sell |
41,312
-14,488
| -26% | -$285K | 0.02% | 890 |
|
|
2022
Q1 | $2.36M | Buy |
55,800
+30,683
| +122% | +$1.3M | 0.06% | 457 |
|
|
2021
Q4 | $1.6M | Buy |
+25,117
| New | +$1.6M | 0.03% | 696 |
|
|
2021
Q2 | – | Sell |
-5,542
| Closed | -$215K | – | 1662 |
|
|
2021
Q1 | $215K | Sell |
5,542
-10,511
| -65% | -$408K | ﹤0.01% | 1391 |
|
|
2020
Q4 | $995K | Sell |
16,053
-75,463
| -82% | -$4.68M | 0.03% | 694 |
|
|
2020
Q3 | $2.96M | Buy |
+91,516
| New | +$2.96M | 0.13% | 175 |
|